摘要
目的:分析患者FT3水平与采用131碘治疗甲状腺功能亢进19项因素相关关系,为探讨采用131碘治疗甲状腺功能亢进引起暂时性甲状腺功能减退的危险因素提供线索。方法:运用spearman相关分析方法,将患者FT3水平与19个因素作相关分析。结果:甲状腺质量(g)、24h甲状腺最大摄131碘率(%)、131碘实际用量(uCi)、每克甲状腺给131碘量(uCi/g)、每kg体重给131碘量(uCi/kg)、每周岁给131碘量(uCi/周岁)、甲状肿大程度(Ⅰ、Ⅱ、Ⅲ)、甲状腺体积(mm3)、B超医生从事甲状腺检查工作年数、131碘放射性化学纯度(%)、放射性浓度(mCi/mL)、131碘从出厂到使用时间(h)存在较弱相关关系。结论:上述12项因素对采用131碘治疗甲亢后患者FT3水平有一定程度影响。
Objective:To provide clues for the risk factors of temporary hypothyroidism caused by 131 iodine therapy,Analyzing correlation between FT3 levels and the 19 factors treated hyperthyroidism with131 iodine.Methods:Using spearman correlation method analysis correlation for FT3 levels and 19 factors.Results:There is weak correlation between FT3 levels and thyroid mass (g),maximal rate of thyroid take131 iodine by24 hours(%),the actual amount of131 iodine (uCi),per gram of thyroid provide 131 iodine (uCi /g),per kg body weight provide 131 iodine (uCi /kg),every years provide 131 iodine (uCi /years),degree of thyroid enlargement (Ⅰ、Ⅱ、Ⅲ),thyroid volume (mm3),B ultrasound-doctor Seniority for checks thyroid,radioactive chemical purity (%),radioactive concentration (mCi /ml),the time of 131 iodine from producing to the using (hours).Conclusions:The 12 factors use 131 iodine treat hyperthyroidism hand some extent impact to FT3 level.
出处
《航空航天医药》
2010年第7期1086-1087,共2页
Aerospace Medicine
基金
2007年广西教育厅科研项目
项目编号:(200710MS089)